We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
At its 8th Annual Scholarship & Awards Banquet, the Young Men and Women in Charge (YMWIC) Foundation presented West Pharmaceutical Services, Inc. with the organization’s first-ever Impact Award.
West is a longtime supporter of the YMWIC Foundation, whose mission is to empower and prepare economically disadvantaged and historically underrepresented youth to excel and become leaders in STEM careers through academic tutoring, mentoring and financial assistance programs, accomplished by leveraging alliances with K-12 school districts, universities, corporations, and committed partners.
West was given the Impact Award for providing continued support, resources and guidance that have been critical to sustaining YMWIC programming. Moving forward, the award will be known as the West Impact Award. It will be awarded annually to organizations who, like West, are socially responsible and connected to and making significant impacts in the community by improving the quality of life for others, educating and inspiring youth to pursue academic excellence particularly in STEM-related courses, and embracing a culture of philanthropy and community involvement.
“West’s impact has been life changing,” said Richard Roberts III, the founder and President of YMWIC. “The generous contributions from West Pharmaceutical Services have impacted our 25 alum and more than 300 young men and women scholars across the region in Chester, Montgomery, Delaware and Philadelphia counties.”
The important mission of YMWIC is consistent with two of the four focus areas in West’s corporate giving strategy: supporting children and STEM education. West has supported YMWIC for the past eight years and, in that time, has generously donated more than $250,000 to their cause. The funds donated to YMWIC are used to provide scholarships for local students entering college in STEM fields of study.
In addition to donations, West takes an active role in mentoring the youth from the YMWIC Foundation through job shadowing and internship opportunities. This month, we welcomed 40 local middle and high school students to our corporate headquarters where they met with West team members from a variety of business functions to learn more about the careers available at West.
“By supporting an important organization like the YMWIC Foundation, we are giving local, underprivileged children an opportunity to pursue careers in STEM,” said Brian Stocker, VP, HR, Global Operations for West and member of the YMWIC Foundation Advisory Team. “In doing so, we hope to build a pipeline of STEM professionals who, after completing their education, will consider coming back to work for West.”
West is excited to announce an addition to its NovaPure<sup>®</sup> product line — NovaPure 3mL Cartridge components, which include plunger and seal components specifically designed to ensure consistency of delivery for higher-volume injectable drug delivery systems. The components were designed to address specific issues and challenges the pharmaceutical industry faces in bringing innovative injectable drug products to market.
On January 1, 2018, new USP standards became mandatory for measuring elemental impurities in pharmaceuticals and their ingredients – aligning with ICH Q3D, which provides limits for the amount of elemental impurities in drug products. New USP General Chapters, USP <232> (<em>Elemental Impurities – Limits</em>) and USP <233> (<em>Elemental Impurities – Procedures</em>) have replaced USP <231> (<em>Heavy Metals</em>). USP <231>, which historically was used to test for heavy metals in drug products as well as packaging components, has been withdrawn. However, the heavy metals testing in USP <381> (<em>Elastomeric Closure for Injections</em>), which is used for testing of elastomeric closures, still references USP <231>.
The team at West’s Dublin facility continues to be a strong supporter of Temple Street Children’s Hospital, and in the past seven years has raised over $260,000 for the foundation.
As China has become the fastest-growing market in generic drugs, China Food and Drug Administration (CFDA) is paying more attention to drug quality and setting a higher standard for pharmaceutical packaging. Compatibility of the drug with the packaging materials is one critical focus area.</br>
Tech Group Europe partnered with Temple Street Children’s Hospital for the 2012 West without Borders campaign.
English
Chinese
